GDUFA Research Outcomes
MR Oral Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to modified release generic drug products.
-
Summary of 2nd GBHI Worshop Session IV: Exclusion of Pharmacokinetic Data is Bioequivalence Assessment
Jiang, Wenlei
-
Equivalence Criteria for In Vitro BE Tests for Locally Acting Drug Products: The Earth Mover’s Distance Approach
Hu, Meng
-
Development of PBPK Model for Predicting Food Impact on BE Assessment
Shoyaib, Abdullah
-
Generic Oral Modified Release Drug Products: Establishing Bioequivalence for Additional Strengths
Sun, Wei Jhe; Wang, Rong
-
Potential Impact of Gastric pH on Generic Drug Bioequivalence Evaluation
Fan, Jianghong
-
PBPK Absorption Modeling to Support Risk Assessment and Biowaiver for Generic Oral Products
Wu, Fang
-
Establishing Bioequivalence for “Additional Strengths” of Oral Modified-Release Drug Products
Boyce, Heather
-
In Vitro Evaluation of Excipients as Inhibitors of Human Intestinal P-glycoprotein
Bajaj, R; Chong, L; Zhou, L; Tsakalozou, E; Ni, Z; Giacomini, K; Kroetz D
-
Stability of Pantoprazole Sodium Delayed Release Granules When Sprinkled on Soft Foods
Zheng, Kai; Jordan, Lorne; Tian, Li; Hoover, Alicia; Mahjabeen, Sanjida; Sun, Wei Jhe; Xia, Li; Lee, Sue Chih; Hwang, Sung Yong; Nwakama, Patrick; Xi, Xinyuan; Kim, Myong Jin; Tampal, Nilufer; Boyce, Heather; Feng, Xin
-
In Vitro Performance of Pantoprazole Sodium Delayed Release Granules when Sprinkled on Soft Foods
Zheng, Kai; Jordan, Lorne; Tian, Li; Hoover, Alicia; Mahjabeen, Sanjida; Sun, Wei Jhe; Xia, Li; Lee, Sue Chih; Hwang, Sung Yong; Nwakama, Patrick; Xi, Xinyuan; Kim, Myong Jin; Tampal, Nilufer; Boyce, Heather; Feng, Xin